144 related articles for article (PubMed ID: 22586480)
21. Central line-associated bloodstream infections in Australian ICUs: evaluating modifiable and non-modifiable risks in Victorian healthcare facilities.
Spelman T; Pilcher DV; Cheng AC; Bull AL; Richards MJ; Worth LJ
Epidemiol Infect; 2017 Oct; 145(14):3047-3055. PubMed ID: 28868995
[TBL] [Abstract][Full Text] [Related]
22. Central line-associated bloodstream infections in Australian intensive care units: Time-trends in infection rates, etiology, and antimicrobial resistance using a comprehensive Victorian surveillance program, 2009-2013.
Worth LJ; Spelman T; Bull AL; Brett JA; Richards MJ
Am J Infect Control; 2015 Aug; 43(8):848-52. PubMed ID: 26026826
[TBL] [Abstract][Full Text] [Related]
23. Multicenter study in Colombia: Impact of a multidimensional International Nosocomial Infection Control Consortium (INICC) approach on central line-associated bloodstream infection rates.
Álvarez-Moreno CA; Valderrama-Beltrán SL; Rosenthal VD; Mojica-Carreño BE; Valderrama-Márquez IA; Matta-Cortés L; Gualtero-Trujillo SM; Rodríguez-Peña J; Linares-Miranda CJ; Gonzalez-Rubio ÁP; Vega-Galvis MC; Riaño-Forero I; Ariza-Ayala BE; García-Laverde G; Susmann O; Mancera-Páez O; Olarte N; Rendón-Campo LF; Astudillo Y; Trullo-Escobar MD; Orellano PW
Am J Infect Control; 2016 Nov; 44(11):e235-e241. PubMed ID: 27317408
[TBL] [Abstract][Full Text] [Related]
24. A hospital-wide reduction in central line-associated bloodstream infections through systematic quality improvement initiative and multidisciplinary teamwork.
Han J; Wan J; Cheng Y; Li D; Deng M; Wang X; Feng J; He Y; Ye Q; Wang L; Lei Y; Wang J
Am J Infect Control; 2019 Nov; 47(11):1358-1364. PubMed ID: 31277999
[TBL] [Abstract][Full Text] [Related]
25. The association between implementation of second-tier prevention practices and CLABSI incidence: A national survey.
Ben-David D; Vaturi A; Solter E; Temkin E; Carmeli Y; Schwaber MJ;
Infect Control Hosp Epidemiol; 2019 Oct; 40(10):1094-1099. PubMed ID: 31339089
[TBL] [Abstract][Full Text] [Related]
26. Eliminating central line-associated bloodstream infections: a national patient safety imperative.
Berenholtz SM; Lubomski LH; Weeks K; Goeschel CA; Marsteller JA; Pham JC; Sawyer MD; Thompson DA; Winters BD; Cosgrove SE; Yang T; Louis TA; Meyer Lucas B; George CT; Watson SR; Albert-Lesher MI; St Andre JR; Combes JR; Bohr D; Hines SC; Battles JB; Pronovost PJ;
Infect Control Hosp Epidemiol; 2014 Jan; 35(1):56-62. PubMed ID: 24334799
[TBL] [Abstract][Full Text] [Related]
27. 'Matching Michigan': a 2-year stepped interventional programme to minimise central venous catheter-blood stream infections in intensive care units in England.
Bion J; Richardson A; Hibbert P; Beer J; Abrusci T; McCutcheon M; Cassidy J; Eddleston J; Gunning K; Bellingan G; Patten M; Harrison D;
BMJ Qual Saf; 2013 Feb; 22(2):110-23. PubMed ID: 22996571
[TBL] [Abstract][Full Text] [Related]
28. Multicenter prospective study on device-associated infection rates and bacterial resistance in intensive care units of Venezuela: International Nosocomial Infection Control Consortium (INICC) findings.
Empaire GD; Guzman Siritt ME; Rosenthal VD; Pérez F; Ruiz Y; Díaz C; Di Silvestre G; Salinas E; Orozco N
Int Health; 2017 Jan; 9(1):44-49. PubMed ID: 28096455
[TBL] [Abstract][Full Text] [Related]
29. Central line-associated bloodstream infection in neonatal intensive care units.
Blanchard AC; Fortin E; Rocher I; Moore DL; Frenette C; Tremblay C; Quach C
Infect Control Hosp Epidemiol; 2013 Nov; 34(11):1167-73. PubMed ID: 24113600
[TBL] [Abstract][Full Text] [Related]
30. Time-series analysis to observe the impact of a centrally organized educational intervention on the prevention of central-line-associated bloodstream infections in 32 German intensive care units.
Hansen S; Schwab F; Schneider S; Sohr D; Gastmeier P; Geffers C
J Hosp Infect; 2014 Aug; 87(4):220-6. PubMed ID: 24973015
[TBL] [Abstract][Full Text] [Related]
31. Decreasing central-line-associated bloodstream infections in Connecticut intensive care units.
Hong AL; Sawyer MD; Shore A; Winters BD; Masuga M; Lee H; Mathews SC; Weeks K; Goeschel CA; Berenholtz SM; Pronovost PJ; Lubomski LH;
J Healthc Qual; 2013; 35(5):78-87. PubMed ID: 23347278
[TBL] [Abstract][Full Text] [Related]
32. Surveillance of device-associated infection rates and mortality in 3 Greek intensive care units.
Apostolopoulou E; Raftopoulos V; Filntisis G; Kithreotis P; Stefanidis E; Galanis P; Veldekis D
Am J Crit Care; 2013 May; 22(3):e12-20. PubMed ID: 23635940
[TBL] [Abstract][Full Text] [Related]
33. Impact of the International Nosocomial Infection Control Consortium (INICC)'s Multidimensional Approach on Rates of Central Line-Associated Bloodstream Infection in 14 Intensive Care Units in 11 Hospitals of 5 Cities in Argentina.
Rosenthal VD; Desse J; Maurizi DM; Chaparro GJ; Orellano PW; Chediack V; Cabrera R; Golschmid D; Silva CG; Vimercati JC; Stagnaro JP; Perez I; Spadaro ML; Montanini AM; Pedersen D; Paniccia TL; Aguilera AMR; Cermesoni R; Mele JI; Alda E; Paldoro AE; Ortta AR; Cooke B; García MC; Obed MN; Domínguez CV; Saúl PA; Rodríguez Del Valle MC; Bianchi AC; Alvarez G; Pérez R; Oyola C
Infect Control Hosp Epidemiol; 2018 Apr; 39(4):445-451. PubMed ID: 29427997
[TBL] [Abstract][Full Text] [Related]
34. Statewide validation of hospital-reported central line-associated bloodstream infections: Oregon, 2009.
Oh JY; Cunningham MC; Beldavs ZG; Tujo J; Moore SW; Thomas AR; Cieslak PR
Infect Control Hosp Epidemiol; 2012 May; 33(5):439-45. PubMed ID: 22476268
[TBL] [Abstract][Full Text] [Related]
35. Device-associated nosocomial infection in general hospitals, Kingdom of Saudi Arabia, 2013-2016.
Gaid E; Assiri A; McNabb S; Banjar W
J Epidemiol Glob Health; 2018 Mar; 7 Suppl 1(Suppl 1):S35-S40. PubMed ID: 29801591
[TBL] [Abstract][Full Text] [Related]
36. Device-associated infection rates in 398 intensive care units in Shanghai, China: International Nosocomial Infection Control Consortium (INICC) findings.
Tao L; Hu B; Rosenthal VD; Gao X; He L
Int J Infect Dis; 2011 Nov; 15(11):e774-80. PubMed ID: 21846591
[TBL] [Abstract][Full Text] [Related]
37. Impact of multiple concurrent central lines on central-line-associated bloodstream infection rates.
Couk J; Chernetsky Tejedor S; Steinberg JP; Robichaux C; Jacob JT
Infect Control Hosp Epidemiol; 2019 Sep; 40(9):1019-1023. PubMed ID: 31337455
[TBL] [Abstract][Full Text] [Related]
38. Effect of central line bundle on central line-associated bloodstream infections in intensive care units.
Jeong IS; Park SM; Lee JM; Song JY; Lee SJ
Am J Infect Control; 2013 Aug; 41(8):710-6. PubMed ID: 23394886
[TBL] [Abstract][Full Text] [Related]
39. Establishing nationally representative central line-associated bloodstream infection surveillance data for paediatric patients in Greece.
Kouni S; Tsolia M; Roilides E; Dimitriou G; Tsiodras S; Skoutelis A; Kourkouni E; Gkentzi D; Iosifidis E; Spyridis N; Kopsidas I; Karakosta P; Tsopela GC; Spyridaki I; Kourlaba G; Coffin S; Zaoutis ET;
J Hosp Infect; 2019 Jan; 101(1):53-59. PubMed ID: 30059747
[TBL] [Abstract][Full Text] [Related]
40. Trends in validity of central line-associated bloodstream infection surveillance data, New York State, 2007-2010.
Hazamy PA; Van Antwerpen C; Tserenpuntsag B; Haley VB; Tsivitis M; Doughty D; Gase KA; Tucci V; Stricof RL
Am J Infect Control; 2013 Dec; 41(12):1200-4. PubMed ID: 24035214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
